Early Detection of Chemotherapy‐Induced Glucose Metabolic Alterations in Bladder Carcinoma Using Deuterium ( 2 H) Metabolic Imaging: in Vitro and in Vivo Assessments
Advanced Science · 2026
DOI: 10.1002/advs.202514614 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Lingmin Kong und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The First Affiliated Hospital, Sun Yat-sen University, 58 Zhongshan Road 2, Guangzhou, Guangdong, 510080, P. R. China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Deuterium, Glucose, Antineoplastic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Outstanding Youth Fund Project of Guangdong province, China, Youth Medical Innovation and Practice Research Program of Guangzhou.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Deuterium metabolic imaging (DMI) is a promising noninvasive technique for assessing tumor metabolism, yet its application in bladder cancer (BCa) remains unexplored. This study presents the first demonstration of DMI for evaluating therapeutic response in BCa through in vitro and in vivo experiments. Two types of deuterium‐labeled glucose tracers, [6,6′‐ 2 H 2 ]‐D‐glucose and [2,3,4,6,6′‐ 2 H 5 ]‐D‐glucose, are systematically compared for their efficacy in capturing glycolytic activity and treatment‐induced metabolic changes in BCa models. In subcutaneous tumors, deuterium magnetic resonance spectroscopy and spectroscopic imaging reveal pronounced suppression of glycolytic flux following chemotherapy, underscoring the potential of DMI for early therapeutic response assessment in BCa treatment. Both tracers consistently detect these chemotherapy‐related metabolism shifts in both vitro and in vivo experiments, indicating the translational advantage of [2,3,4,6,6′‐ 2 H 5 ]‐D‐glucose as a cost‐effective alternative to [6,6′‐ 2 H 2 ]‐D‐glucose. Notably, subcutaneous administration yields metabolic profiles comparable to intravenous delivery. Finally, the optimized lower‐dose, subcutaneous [2,3,4,6,6′‐ 2 H 5 ]‐D‐glucose protocol is successfully validated in orthotopic BCa models. These results demonstrate DMI as a reliable tool for non‐invasive monitoring of therapeutic response in BCa, with practical potential for future clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, The First Affiliated Hospital, Sun Yat-sen University, 58 Zhongshan Road 2, Guangzhou, Guangdong, 510080, P. R. China.
- The School of Electronics and Information Engineering, Harbin Institute of Technology, Harbin, 150001, P. R. China.
- Paul C. Lauterbur Research Center for Biomedical Imaging, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, 518055, P. R. China.
- Department of Radiology, University of Cambridge, Cambridge, CB2 0QQ, UK.
- Key Laboratory for Magnetic Resonance, Multimodality Imaging of Guangdong Province, Shenzhen, Guangdong, 518055, P. R. China.
- State Key Laboratory of Biomedical Imaging Science, System, Shenzhen, Guangdong, 518055, P. R. China.
ORCID-Profile: Huanjun Wang
Förderung
- National Natural Science Foundation of China
- Natural Science Outstanding Youth Fund Project of Guangdong province, China
- Youth Medical Innovation and Practice Research Program of Guangzhou
- Basic and Applied Basic Research Foundation of Guangdong Province, China
- Project on Global Common Challenges of the Chinese Academy of Sciences
- Key Laboratory for Magnetic Resonance and Multimodality Imaging of Guangdong Province
- Strategic Priority Research Program of the Chinese Academy of Sciences
- National Key R&D Program of China
Zitieren
APA
Kong, L., Yang, G., Weng, B., Wen, Z., Kaggie, J. D., Cai, Q., Wan, Q., Zheng, C., Du, F., Li, Y., Liu, X., Gallagher, F. A., Guo, Y., Feng, S. T., Zou, C., & Wang, H. (2026). Early Detection of Chemotherapy‐Induced Glucose Metabolic Alterations in Bladder Carcinoma Using Deuterium ( 2 H) Metabolic Imaging: in Vitro and in Vivo Assessments. Advanced Science. https://doi.org/10.1002/advs.202514614
Vancouver
Kong L, Yang G, Weng B, Wen Z, Kaggie JD, Cai Q, et al. Early Detection of Chemotherapy‐Induced Glucose Metabolic Alterations in Bladder Carcinoma Using Deuterium ( 2 H) Metabolic Imaging: in Vitro and in Vivo Assessments. Advanced Science. 2026. doi:10.1002/advs.202514614
BibTeX
@article{Kong2026,
author = {Kong, Lingmin and Yang, Ganghan and Weng, Bei and Wen, Zhihua and Kaggie, Joshua D and Cai, Qian and Wan, Qian and Zheng, Cuien and Du, Feng and Li, Ye and Liu, Xin and Gallagher, Ferdia A and Guo, Yan and Feng, Shi-Ting and Zou, Chao and Wang, Huanjun},
title = {Early Detection of Chemotherapy‐Induced Glucose Metabolic Alterations in Bladder Carcinoma Using Deuterium ( 2 H) Metabolic Imaging: in Vitro and in Vivo Assessments},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202514614}
}
EUVIMED